Yubo International Biotech LimitedYubo International Biotech LimitedYubo International Biotech Limited

Yubo International Biotech Limited

No trades
See on Supercharts
Market capitalization
‪91.42 M‬USD
−0.0100USD
‪−1.20 M‬USD
‪604.68 K‬USD
‪7.95 M‬
Beta (1Y)
7.80

About Yubo International Biotech Limited

CEO
Jun Wang
Headquarters
Beijing
Employees (FY)
18
Founded
1991
FIGI
BBG000BGL6K2
Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. Its products include Life Shinkansen Liquid Dressing and Life Shinkansen Spray Dressing. The company was founded by Lawrence A. Minkoff on February 22, 1991 and is headquartered in Beijing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of YBGJ is 0.9500 USD — it has decreased by 0.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Yubo International Biotech Limited stocks are traded under the ticker YBGJ.
YBGJ stock is 68.87% volatile and has beta coefficient of 7.80. Check out the list of the most volatile stocks — is Yubo International Biotech Limited there?
Yes, you can track Yubo International Biotech Limited financials in yearly and quarterly reports right on TradingView.
YBGJ net income for the last quarter is ‪−517.38 K‬ USD, while the quarter before that showed ‪6.29 K‬ USD of net income which accounts for ‪−8.32 K‬% change. Track more Yubo International Biotech Limited financial stats to get the full picture.
No, YBGJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, YBGJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Yubo International Biotech Limited stock right from TradingView charts — choose your broker and connect to your account.
YBGJ reached its all-time high on Mar 30, 1993 with the price of 712.5000 USD, and its all-time low was 0.0022 USD and was reached on Apr 29, 2013.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 18.00 employees. See our rating of the largest employees — is Yubo International Biotech Limited on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Yubo International Biotech Limited technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Yubo International Biotech Limited stock shows the buy signal. See more of Yubo International Biotech Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Yubo International Biotech Limited EBITDA is ‪−1.01 M‬ USD, and current EBITDA margin is −166.15%. See more stats in Yubo International Biotech Limited financial statements.